Genova Diagnostics Appoints Keith Meadors as Chief Commercial Officer for Growth Phase

Genova Diagnostics Welcomes Keith Meadors as Chief Commercial Officer

In a strategic move aimed to support its next phase of growth, Genova Diagnostics has officially appointed Keith Meadors, an accomplished leader in the healthcare sector, as Chief Commercial Officer. Meadors is stepping into this role during a crucial period for the company as it continues to expand its capabilities in the diagnostic testing market.

A Leader with Experience

Keith Meadors brings more than 30 years of integrated experience in clinical diagnostics, pharmaceuticals, and medical devices to Genova. His previous roles have equipped him with a robust skill set that focuses on driving disciplined growth and fostering high-performance culture within commercial organizations in complex healthcare landscapes.

Before joining Genova, Meadors served at Labcorp as the Vice President and General Manager for the South Atlantic region. There, he was responsible for several key initiatives aimed at growth, such as enhancing customer partnerships, increasing market share through innovative tests, and revolutionizing operational workflows. His tenure at Labcorp demonstrated his capability to execute growth-oriented strategies aligned with shifting healthcare landscapes.

Meadors has also held senior roles at notable companies, including Precipio, Fresenius Kabi, Hospira (a Pfizer subsidiary), and Becton Dickinson. His consistent track record of success speaks to his ability to merge commercial strategies with the evolving needs of the healthcare industry and encourage team accountability.

Vision for Genova Diagnostics

As Chief Commercial Officer at Genova Diagnostics, Meadors will spearhead the company's commercial strategy, strengthening existing customer relationships and advancing growth initiatives across its diagnostics portfolio.